HCID 178425160, compound → HCID 178425161, compound
Reaction equation
[OH:1][C:2]1[C:7]([CH2:8][NH:9][C:10](=[O:26])[C:11]2[CH:16]=[CH:15][C:14]([CH:17]([N:19]3[CH:24]=[CH:23][CH:22]=[CH:21][C:20]3=[O:25])[CH3:18])=[CH:13][CH:12]=2)=[C:6]([CH3:27])[CH:5]=[C:4]([CH3:28])[N:3]=1>CO.[Pd]>[OH:1][C:2]1[C:7]([CH2:8][NH:9][C:10](=[O:26])[C:11]2[CH:12]=[CH:13][C:14]([CH:17]([N:19]3[CH2:24][CH2:23][CH2:22][CH2:21][C:20]3=[O:25])[CH3:18])=[CH:15][CH:16]=2)=[C:6]([CH3:27])[CH:5]=[C:4]([CH3:28])[N:3]=1Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of N-((2-hydroxy-4,6-dimethylpyridin-3-yl)methyl)-4-(1-(2-oxopyridin-1(2H)-yl)ethyl)benzamide (30 mg, 0.08 mmol) in methanol was added palladium on carbon (30 mg). The mixture was stirred at room temperature for 12 hours under hydrogen atmosphere. Then the mixture was filtered and the filtrate was concentrated to give N-((2-hydroxy-4,6-dimethylpyridin-3-yl)methyl)-4-(1-(2-oxopiperidin-1-yl)ethyl)benzamide (21 mg, 67%). LRMS (M+H) m/z: calcd 381.19. found 381. HPLC purity (214 nm): 95%. 1H NMR (300 MHz, CD3OD): δ 7.78 (d, J=8.1 Hz, 2H), 7.36 (d, J=8.1 Hz, 2H), 6.10 (s, 1H), 6.00 (q, J=6.9 Hz, 1H), 4.49 (s, 2H), 3.23-3.19 (m, 1H), 2.83-2.79 (m, 1H), 2.46-2.42 (m, 2H), 2.36 (s, 3H), 2.24 (s, 3H), 1.81-1.63 (m, 4H), 1.54 (d, J=6.9 Hz, 3H).
Workup
- filtrationThen the mixture was filtered
- concentrationthe filtrate was concentrated
Sources & evidence
- ORD record
- ord-61fb962e968a4e5e94ce5cab1fa9ff09
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09206128B2
Reaction notes
Loading…